The decision to prescribe medication is made with careful consideration, aiming to support each patient's journey towards achieving and maintaining a healthy weight
At the primary 32-week endpoint, 82.0% of participants on 6 mg achieved at least 5% weight loss compared to 10.5% with placebo
Most patients report reduced appetite and initial weight loss (24 lbs) within the first 23 weeks as hormone signaling engages
Metabolic profile to assess kidney function and serum electrolyte levels
coli OMVs Carrying the Membrane-Binding hGC33 Fragment Precisely Target Liver Cancer and Effectively Treat Tumor Yufei Deng, Bangya Yang, Zelan Yang, Hanyu Xiao, Yan Zou, Cheng Zou, Song Yang, Xi Sun, Yiting Wang, Jin Bai, Liaoqiong Fang, Zhibiao Wang International Journal of Nanomedicine .2025